Brought to you by:
‘Let’s move on to solutions,’ keynote speaker tells diversity, equity and inclusion focus session
Lee Kirksey, MD, issued an unapologetic apology of sorts at the outset of his discussion of diversity, equity and inclusion (DEI) issues. “If I ruffle any feathers I apologize, but I think it’s a conversation that’s important to have,” said…
Colombian researchers report positive 24-month results for VenoValve
Promising two-year results for an emerging potential prosthetic venous valve replacement—which is about to commence a U.S. pivotal trial—were announced at the Vascular Annual Meeting (VAM) in San Diego on Thursday afternoon. Researchers from Bogota, Colombia, revealed that patients treated…
Research letter highlights low adoption of supervised exercise therapy for PAD
A research letter published in Circulation: Cardiovascular Quality and Outcomes highlights a “very low” utilization of supervised exercise therapy (SET) in symptomatic peripheral arterial disease (PAD) patients during the first 19 months after approval by the Centers for Medicare & Medicaid Services (CMS)…
VOYAGER PAD: Rivaroxaban plus aspirin should be considered after lower-extremity bypass regardless of conduit type
“A strategy of adding rivaroxaban 2.5mg twice daily to aspirin should be considered after lower extremity bypass regardless of conduit type,” concluded Nicholas Govsyeyev, MD, during the William J. von Liebig Forum at the Vascular Annual Meeting (VAM) in San…
PRISTINE registry with Selution SLR sirolimus drug-eluting balloon completes enrollment
MedAlliance has announced completion of patient enrollment in the PRISTINE clinical trial with the Selution SLR 018 drug-eluting balloon (DEB) for the treatment of patients with below-the-knee (BTK) disease. According to a MedAlliance press release, Selution SLR is the first DEB to be…
VAM: Industry-sponsored symposia
Industry-sponsored symposia at the Vascular Annual Meeting (VAM) will be presented Wednesday and Thursday evenings and at three breakfast sessions taking place Thursday morning. Industry-supported evening Satellite Symposia will be held from 6:30 to 8 p.m. Wednesday and Thursday. Wednesday’s…
Study of amputees finds referral for prosthetics to be an independent predictor of long-term survival
Prosthetic referral was an independent predictor of long-term survival among patients who had undergone lower-extremity amputation, new findings set to be published in the Journal of Vascular Surgery will reveal. A single-center retrospective study by William Shutze, MD, a vascular…
AHA publishes updated scientific statement on PAD
The American Heart Association (AHA) has released a new scientific statement on lower extremity peripheral arterial disease (PAD), focusing on contemporary epidemiology, management gaps, and future directions. The statement, authored by Michael H. Criqui, MD, a distinguished professor in the division of preventive…
Special session on diversity enters VAM agenda
Over the course of more than a year, diversity, equity and inclusion (DEI) have been brought into sharp focus by a compendium of events inside and outside of medicine. As U.S. society has reckoned with the socioeconomic and cultural consequences…
The year in COVID: VAM to feature 10 talks probing pandemic-related vascular complications
After nearly 18 months of life dominated by a worldwide pandemic—one that canceled the 2020 Vascular Annual Meeting (VAM)—VAM 2021 highlights several aspects of COVID-19 in a special session. The coronavirus session will be from 5 to 6:30 p.m. Wednesday…